In conclusion, our results confirm that mutations in CEP164 can result in a broadly variable clinical outcome between and within families, varying from non-syndromic retinal degeneration to a BBS-like phenotype, which implies that there are restrictions on making an accurate diagnosis and prognosis in these families. Here, CEP164 is linked to retinal degeneration.